Medical - Vaccine Guide 2022 - 17

Notes Recommended Child and Adolescent Immunization Schedule for ages 18 years or younger, United States, 2022
Chronic liver disease, alcoholism:
Age 6-18 years
y No history of PPSV23: 1 dose PPSV23 (at least 8 weeks after any prior
PCV13 dose)
* Incomplete series = Not having received all doses in either the
recommended series or an age-appropriate catch-up series
See Tables 8, 9, and 11 in the ACIP pneumococcal vaccine
recommendations (www.cdc.gov/mmwr/pdf/rr/rr5911.pdf) for
complete schedule details.
Poliovirus vaccination
(minimum age: 6 weeks)
Routine vaccination
y 4-dose series at ages 2, 4, 6-18 months, 4-6 years; administer the
final dose on or after age 4 years and at least 6 months after the
previous dose.
y 4 or more doses of IPV can be administered before age 4 years when
a combination vaccine containing IPV is used. However, a dose is still
recommended on or after age 4 years and at least 6 months after the
previous dose.
Catch-up vaccination
y In the first 6 months of life, use minimum ages and intervals only
for travel to a polio-endemic region or during an outbreak.
y IPV is not routinely recommended for U.S. residents age 18 years
or older.
Series containing oral polio vaccine (OPV), either mixed OPV-IPV or
OPV-only series:
y Total number of doses needed to complete the series is the same
as that recommended for the U.S. IPV schedule. See www.cdc.gov/
mmwr/volumes/66/wr/mm6601a6.htm?s_%20cid=mm6601a6_w.
y Only trivalent OPV (tOPV) counts toward the U.S. vaccination
requirements.
- Doses of OPV administered before April 1, 2016, should be
counted (unless specifically noted as administered during a
campaign).
- Doses of OPV administered on or after April 1, 2016, should not
be counted.
- For guidance to assess doses documented as " OPV, " see
www.cdc.gov/mmwr/volumes/66/wr/mm6606a7.htm?s_
cid=mm6606a7_w.
y For other catch-up guidance, see Table 2.
Rotavirus vaccination
(minimum age: 6 weeks)
Routine vaccination
y Rotarix®: 2-dose series at age 2 and 4 months
y RotaTeq®: 3-dose series at age 2, 4, and 6 months
y If any dose in the series is either RotaTeq® or unknown, default to
3-dose series.
Catch-up vaccination
y Do not start the series on or after age 15 weeks, 0 days.
y The maximum age for the final dose is 8 months, 0 days.
y For other catch-up guidance, see Table 2.
Tetanus, diphtheria, and pertussis (Tdap)
vaccination
(minimum age: 11 years for routine vaccination,
7 years for catch-up vaccination)
Routine vaccination
y Adolescents age 11-12 years: 1 dose Tdap
y Pregnancy: 1 dose Tdap during each pregnancy, preferably in
early part of gestational weeks 27-36.
y Tdap may be administered regardless of the interval since the last
tetanus- and diphtheria-toxoid-containing vaccine.
Catch-up vaccination
y Adolescents age 13-18 years who have not received Tdap:
1 dose Tdap, then Td or Tdap booster every 10 years
y Persons age 7-18 years not fully vaccinated*
with DTaP: 1 dose
Tdap as part of the catch-up series (preferably the first dose); if
additional doses are needed, use Td or Tdap.
y Tdap administered at age 7-10 years:
- Children age 7-9 years who receive Tdap should receive the
routine Tdap dose at age 11-12 years.
- Children age 10 years who receive Tdap do not need the routine
Tdap dose at age 11-12 years.
y DTaP inadvertently administered on or after age 7 years:
- Children age 7-9 years: DTaP may count as part of catch-up
series. Administer routine Tdap dose at age 11-12 years.
- Children age 10-18 years: Count dose of DTaP as the adolescent
Tdap booster.
y For other catch-up guidance, see Table 2.
Special situations
yWound management in persons age 7 years or older with history
of 3 or more doses of tetanus-toxoid-containing vaccine: For clean
and minor wounds, administer Tdap or Td if more than 10 years
since last dose of tetanus-toxoid-containing vaccine; for all other
wounds, administer Tdap or Td if more than 5 years since last dose of
tetanus-toxoid-containing vaccine. Tdap is preferred for persons age
11 years or older who have not previously received Tdap or whose
Tdap history is unknown. If a tetanus-toxoid-containing vaccine is
indicated for a pregnant adolescent, use Tdap.
y For detailed information, see www.cdc.gov/mmwr/volumes/69/wr/
mm6903a5.htm.
*Fully vaccinated = 5 valid doses of DTaP OR 4 valid doses of DTaP if
dose 4 was administered at age 4 years or older
Varicella vaccination
(minimum age: 12 months)
Routine vaccination
y 2-dose series at age 12-15 months, 4-6 years
y VAR or MMRV may be administered*
y Dose 2 may be administered as early as 3 months after dose 1
(a dose inadvertently administered after at least 4weeks may be
counted as valid)
*Note: For dose 1 in children age 12-47 months, it is recommended to
administer MMR and varicella vaccines separately. MMRV may be used
if parents or caregivers express a preference.
Catch-up vaccination
y Ensure persons age 7-18 years without evidence of immunity (see
MMWR at www.cdc.gov/mmwr/pdf/rr/rr5604.pdf) have a 2-dose
series:
- Age 7-12 years: routine interval: 3 months (a dose inadvertently
administered after at least 4 weeks may be counted as valid)
- Age 13 years and older: routine interval: 4-8 weeks (minimum
interval: 4 weeks)
- The maximum age for use of MMRV is 12 years.
2/17/2022
Centers for Disease Control and Prevention | Recommended Child and Adolescent Immunization Schedule, United States, 2022
22MS6015
17
henryschein.com/medical

http://www.cdc.gov/mmwr/pdf/rr/rr5911.pdf http://www.cdc.gov/mmwr/pdf/rr/rr5604.pdf http://www.cdc.gov/mmwr/volumes/66/wr/mm6601a6.htm?s_%20cid=mm6601a6_w http://www.cdc.gov/mmwr/volumes/66/wr/mm6601a6.htm?s_%20cid=mm6601a6_w http://www.cdc.gov/mmwr/volumes/66/wr/mm6606a7.htm?s_cid=mm6606a7_w http://www.cdc.gov/mmwr/volumes/66/wr/mm6606a7.htm?s_cid=mm6606a7_w http://www.cdc.gov/mmwr/volumes/69/wr/mm6903a5.htm http://www.cdc.gov/mmwr/volumes/69/wr/mm6903a5.htm http://www.henryschein.com/medical

Medical - Vaccine Guide 2022

Table of Contents for the Digital Edition of Medical - Vaccine Guide 2022